COUGH

This study tested whether a smartphone app called Hyfe Cough Tracker could help monitor and manage coughs in people with various respiratory diseases. Over 600 participants with conditions like COPD, asthma, or COVID-19 used the app to record their coughs for up to 30 days. Resea…

This study aimed to find simple tests that could predict whether people with chronic cough would respond to steroid inhaler treatment. Researchers followed 502 adults with persistent cough for 8+ weeks, testing their blood and breath before treatment. The goal was to identify mar…

This study tested whether a non-invasive radiofrequency treatment could help people with long-term breathing problems after COVID-19. 96 participants who had shortness of breath, cough, or fatigue for over a month were divided into groups to compare the new therapy against standa…

This study tested whether a tablet made from four traditional Indonesian herbs could relieve acute cough better than a placebo. 144 adults with a recent cough took either the herbal medicine or a dummy pill three times daily for one week. Researchers measured changes in cough sev…

This study tested if injections to block a nerve in the neck could reduce chronic cough. Seventeen adults with a cough thought to be caused by an overactive nerve were randomly assigned to receive either the real nerve-block injections or placebo saline injections. Researchers tr…

This study looked at whether taking Robitussin cough syrups helps people feel better in their daily lives when they have a cold. About 244 adults with a recent cough and cold participated from home, using their phones. They compared two approaches: using one syrup day and night, …

This study tested whether a drug called orvepitant could reduce the severity and frequency of chronic cough in people with idiopathic pulmonary fibrosis (IPF), a serious scarring lung disease. In this completed Phase 2 trial, 80 participants tried both the study drug and a placeb…

This early-stage study aimed to understand how a potential cough medicine, camlipixant, behaves in people with impaired liver function. It compared 32 adults with varying degrees of liver problems to healthy volunteers. The main goal was to see if the drug's processing and safety…